Alkermes plc (ALKS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Alkermes plc, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$45.25
+2.10% today
Market cap
$7.4B
Overall quality
59/100
Kronos AI 30-day
+12.4%
5 of 8 simulated paths end higher
Alkermes plc (ALKS) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $7.4B. It trades at $45.25, up 2.10% today, at 115 times earnings. Its overall quality score is 59 out of 100, ranked against the whole US market. 12 analysts' average target of $58.83 implies +30.0% from today's price. Kronos AI's 30-day forecast is +12.4% (5 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $58.83 |
| Low – high | $38.00 – $83.00 |
| Analysts | 12 |
| Upside to average | +30.0% |
Kronos AI 30-day forecast
| Expected close | $49.81 (+12.4%) |
| Likely range | −9.5% … +15.7% |
| As of | 2026-10-27 |
5 of 8 simulated paths end higher.
Quality scores
| Profitability | 55 |
| Solvency | 41 |
| Growth | 80 |
| Overall | 59 |
| P/E | 115 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.